1. Barbour LA, McCurdy CE, Hernandez TL et al. Cellular mechanism for insulin resistance in normal pregnany and gestational diabetes. Diabetes Care 2007;30:S112-S119.
2. Whiteman VE, Homdo CJ, Reece EA. Management of hypoglycemia and diabetic ketoacidosis in pregnancy. Obst Gynecol Clin No America 1996;23(1):87-107
3. Mahoney CA. Extreme gestational starvation ketoacidosis: Case report and review of pathophysiology. Am J Kidney Dis 1992;XX(3):276-80.
4. Lain KY, Catalano PM. Metabolic Changes in Pregnancy. Clin Obstet Gynecol 2007;50:938-48.
5. Diderholm B, Stridsberg M, Ewald U et al. Increased lipolysis in non-obese pregnant women studied in the third trimester. BJOG 2005;112:713-718.
6. Catalano PM, Huston L, Amini SB, Kalhan SC. Longitudinal changes in glucose metabolism during pregnancy in obese women with normal glucose tolerance and gestational diabetes mellitus. Am J Obstet Gynecol 1999;180:903-16.
7. Friedman JE, Ishizuka T, Shao J, Huston L, Highman T, Catalano P. Impaired glucose transport and insulin receptor tyrosine phosphorylation in skeletal muscle from obese women with gestational diabetes. Diabetes 1999;48:1807-14.
8. Kuhl C. Etiology and pathogenesis of gestational diabetes. Diabetes Care 21:B19-26, 1998.
9. Yamashita H, Shao J, Friedman JE. Physiologic and molecular alterations in carbohydrate metabolism during pregnancy and gestational diabetes. Clinical Obstet Gynecol 43:87-98, 2000.
10. Lain KY, Catalano PM. Metabolic Changes in Pregnancy. Clin Obstet Gynecol 2007;50:938-48.
11. Aldoretta PW, Hay WW. Metabolic substrates for fetal energy metabolism and growth. Clin Perinatol 1995;22(1):15-35.
12. Hay Jr WW. Placental supply of energy and protein substrates to the fetus. Acta Pediatr Suppl 1994;405:13-19.
13. Mahoney CA. Extreme gestational starvation ketoacidosis: Case report and review of pathophysiology. Am J Kidney Dis 1992;XX(3):276-80.
14. Hagay ZJ. Dibetic Ketoacidosis in pregnancy: Etiology, pathophysiology, and management. Clinical Obstet Gynecol 1994;37(1):39-49.
15. Ramin KD. Diabetic ketoacidosis in pregnancy. Obstet Gynecol Clin No Amer 1999;26(3):481-87.
16. Lain KY, Catalano PM. Metabolic Changes in Pregnancy. Clin Obstet Gynecol 2007;50:938-48.
17. Illsley NP. Placental glucose transport in diabetic pregnancy. Clinical Obstet Gynecol 2000;43(1):116-26.
18. Garvey WT, Maianu L, Zhu JH, Hancock JA, Golichowski AM. Multiple defects in the adipocyte glucose transport system cause cellular insulin resistance in gestational diabetes. Diabetes 1993;42:1773-85.
19. Okuno S, Akazawa S, Yasuhi I et al. Decreased expression of the GLUT4 glucose transporter protein in adipose tissue during pregnancy. Horm metabol res 1995;27:231-34.
20. Barbour LA, Shao J, Qiao L et al. Human placental growth hormone causes severe insulin resistance in transgenic mice. Am J Obstet Gynceol 2002;186:512-7.
21. Evain-Brion D, Alsat E, Igout A, Frankenne F, Hennen G. Placental growth hormone variant: assay and clinical aspects. Acta Paediatr Suppl 1994;399:49-51.
22. Alsat E, Guibourdenche J, Couturier A, Evain-Brion D. Physiological role of human placental growth hormone. Molec Cell Endocrinol 1998;140:121-27.
23. McIntyre HD, Zeck W, Russell A. lacental growth hormone, fetal growth, and the IGF axis in normal and diabetic pregnancy. Curr Diab Revs 2009;5:185-89.
24. Handwerger S, Freemark M. The roles of placental growth hormone and placental lactogen in the regulation of human fetal growth and development. J Ped Endocrinol Metab 2000;13:343-56.
25. Barbour LA, Shao J, Qiao L et al. Human placental growth hormone causes severe insulin resistance in transgenic mice. Am J Obstet Gynceol 2002;186:512-7.
26. McIntyre HD, Serek R, Crane DI, et al. Placental growth hormone (GH), GH-binding protein, and insulin-like growth factor axis in normal, growth-retarded, and diabetic pregnancies: correlations with fetal growth. J Clin Endocrinol Metab 2000;85:1143-50.
27. Kirwan JP, Hauguel-De Mouzon S, Lepercq J, Challier JC, Huston-Presley L, Friedman JE, Kalhan SC, Catalano PM. TNF-alpha is a predictor of insulin resistance in human pregnancy. Diabetes. 2002 Jul;51(7):2207-13.
28. Handwerger S, Freemark M. The roles of placental growth hormone and placental lactogen in the regulation of human fetal growth and development. J Ped Endocrinol Metab 2000;13:343-56.
29. Brelje TC, Scharp DW, Lacy PE et al. Effect of homologous placental lactogens, prolactins, and growth hormones on islet B-cell division and insulin secretion in rat, mouse, and human islets: implication for placental lactogen regulation of islet function during pregnancy. Endocrinology 1993;132:879-87.
30. Anthony RV, Limesand SW, Fanning MD, Liang R. Placental lactogen and growth hormone. In Bazer FW, editor, endocrinology of pregnancy. Totowa, New Jersey: Humana Press;1998. p.461-90.
31. Barbour LA, McCurdy CE, Hernandez TL et al. Cellular mechanism for insulin resistance in normal pregnany and gestational diabetes. Diabetes Care 2007;30:S112-S119.
32. Lain KY, Catalano PM. Metabolic Changes in Pregnancy. Clin Obstet Gynecol 2007;50:938-48.
33. Yamashita H, Shao J, Friedman JE. Physiologic and molecular alterations in carbohydrate metabolism during pregnancy and gestational diabetes. Clinical Obstet Gynecol 43:87-98, 2000.
34. Lain KY, Catalano PM. Metabolic Changes in Pregnancy. Clin Obstet Gynecol 2007;50:938-48.
35. Lain KY, Catalano PM. Metabolic Changes in Pregnancy. Clin Obstet Gynecol 2007;50:938-48.
36. Diderholm B, Stridsberg M, Ewald U et al. Increased lipolysis in non-obese pregnant women studied in the third trimester. BJOG 2005;112:713-718.
37. Javanovic L, Knopp RH, Brown Z, Conley MR, Park E et al. Declining insulin requirement in the first trimester of diabetic pregnancy. Diabetes Care 2001;24(7):1130-6.
38. Barbour LA, Diabetes in Pregnancy. In Endocrine Secrets, McDermott M ed. Mosby Elsevier 2009, Philadelphia:47-64.
39. Barbour LA, Reusch JE-B. Diabetes in Pregnancy. In McDermott M (ed):, Endocrine Secrets, 3rd ed, Philadelphia, Hanley & Belfus, 2001,308-16.
40. Sacks DA, Feig DS, Amy Liu I-L et al. Managing type 1 diabetes in prgnancy: how near normal is necessary? J Perinat 2006;26:458-62.
41. Montoro MN, Myers VP, Mestman JH, et al. Outcome of pregnancy in diabetic ketoacidosis. Am J Perinatol 1993;10(1)17-20.
42. DeViciana M, Major CA, Morgan MA, Asrat T, Toohey JS, et al. Postprandial versus preprandial blood glucose monitoring in women with gestational diabetes mellitus requiring insulin therapy. N Engl J Med 333:1237-1241, 1995.
43. HAPO Study Cooperative Research Group. Hyperglycemia and Adverse Pregnancy Outcomes. NEJM 2008;358:1991-2002.
44. Ter Braak EW, Evers IM, Erkelens D, Visser GH. Maternal hypoglycemia during pregnancy in type 1 diabetes: maternal and fetal consequences. Diabetes/Metab Res Rev 2002:18(2):96-105.
45. American Diabetes Association. Preconception care of women with diabetes, Diabetes Care 23:S65-68, 2000.
46. Kitzmiller JL, Buchanan TA, Kjos S, Combs CA, Ratner R. Preconception care of diabetes, medical malformations, and spontaneous abortions. Diabetes Care 1996;19:514-41.
47. Temple RC, Aldridge VJ, Murphy HR. Prepregnancy care and pregnancy outcomes in women with type 1 diabetes. Diabetes Care 2006;29:1744-49.
48. Casele HL, Laifer SA. Factors influencing preconception control of glycemia in diabetic women. Arch Intern Med 1998;158:1321-24.
49. Holing EV, Beyer CS, Brown ZA, Connell FA. Why don't women with diabetes plan their pregnancies? Diabetes Care 1998:21(6):889-95.
50. Reece EA, Homko CJ. Why do diabetic women deliver malformed infants? Clicical Obstet Gynecol 2000;43(1):32-45.
51. Yang J, Cummings EA, O’Connell C. Fetal and neonatal outcomes of diabetic pregnancies. Obstet Gynecol 2006;108:644-50.
52. Temple RC, Aldridge VJ, Murphy HR. Prepregnancy care and pregnancy outcomes in women with type 1 diabetes. Diabetes Care 2006;29:1744-49.
53. Garner P. Type I diabetes and pregnancy. Lancet 346:157-161, 1995.
54. Rosenn BM, Menachem M. Medical complications of diabetes mellitus in pregnancy. Clinical Obstet Gynecol 2000;43(1):17-31.
55. Homko CJ, Reece EA. Ambulatory care of the pregnant woman with diabetes. Clinical Obstet Gynecol 1998;41(3):584-96.
56. Dheen ST, Tay SS, Boran J et al. Recent studies on neural tube defects in embryos of diabetic pregnancy: an overview. Curr Medicinal Chem 2009;16:2345-54.
57. Yang J, Cummings EA, O’Connell C. Fetal and neonatal outcomes of diabetic pregnancies. Obstet Gynecol 2006;108:644-50.
58. Casson IF, Clarke CA, Howard CV, McKendrick O, Pennycook S, Pharoah POD et al. Outcomes of pregnancy in insulin dependent diabetic women: results of a five year population cohort study. Br Med J 1997;315:275-78.
59. Hadden DR, McCance DR. Advances in management of Type 1 diabetes and pregnancy. Current Opinion Obstet Gynecol 1999;11(6):557-62.
60. Dheen ST, Tay SS, Boran J et al. Recent studies on neural tube defects in embryos of diabetic pregnancy: an overview. Curr Medicinal Chem 2009;16:2345-54.
61. Kitzmiller JL, Buchanan TA, Kjos S, Combs CA, Ratner R. Preconception care of diabetes, medical malformations, and spontaneous abortions. Diabetes Care 1996;19:514-41.
62. Schaefer UM, Songster G, Xiang A, Berkowitz K, Buchanan TA, Kjos SL. Congenital malformations in offspring of women with hyperglycemia first detected during pregnancy. Am J Obstetric Gynecol 1997;177:1165-71.
63. Diabetes Control and Complications Trial Research Group. Pregnancy outcomes in the diabetes control and compliations trial. Am J Obstet Gynecol 1996;174:1343-53.
64. ACOG Practice Bulletin, Gabbe SG. Pregestatational diabetes mellitus. No. 60, March 2005.
65. Kitzmiller JL, Block JM, Brown FM et al. Managing preexisting diabetes for pregnancy. Summary of evidence and consensus recommendations for care. Diabetes Care 2008;31:1060-79.
66. Hellmuth E, Damm P, Molsted-Pedersen L. Oral hypoglycaemic agents in 118 diabetic pregnancies. Diabetic Med 2000;17(7):507-11.
67. Glueck CJ, Wang P, Kobayashi S, Phillips H, Sieve-Smith. Metformin throughout pregnancy reduces the development of gestational diabetes in women with polycystic ovary syndrome. Fertil Steril 2002;77:520-5.
68. Jakubowicz DJ, Iuorno MJ, Jakubowicz S, Roberts KA, Nestler JE. Effects of metformin on early pregnancy loss in the polycystic ovary syndrome. J Clinical Endo Metab 2002;89(2):524-9.
69. Jakubowicz DJ, Iuorno MJ, Jakubowicz S, Roberts KA, Nestler JE. Effects of metformin on early pregnancy loss in the polycystic ovary syndrome. J Clinical Endo Metab 2002;89(2):524-9.
70. Briggs GC, Freeman RK, Yaffee SJ. Drugs in pregnancy and lactation, 6th edition. Baltimore: Williams and Wilkins 2001.
71. Hellmuth E, Damm P, Molsted-Pedersen L. Oral hypoglycaemic agents in 118 diabetic pregnancies. Diabetic Med 2000;17(7):507-11.
72. Glueck CJ, Wang P, Kobayashi S, Phillips H, Sieve-Smith. Metformin throughout pregnancy reduces the development of gestational diabetes in women with polycystic ovary syndrome. Fertil Steril 2002;77:520-5.
73. Jakubowicz DJ, Iuorno MJ, Jakubowicz S, Roberts KA, Nestler JE. Effects of metformin on early pregnancy loss in the polycystic ovary syndrome. J Clinical Endo Metab 2002;89(2):524-9.
74. Wenzel TM. Role of metformin in the treatment of gestational diabetes. Ann Pharmacother 2009;43:939-43.
75. Moore TR. Glyburide for the treatment of gestational diabetes: a critical appraisal. Diabetes Care 2007;30:S209-13.
76. Metzger BE, Buchanan TA, Coustan DR et al. Summary and recommendations of the Fifth International Workshp-Confernce on gestational diabetes. Diabetes Care 2007;30S251-260.
77. Hebert MF, Ma X, Naraharisetti SB et al. Are we optimizing gestatinl diabetes treatment with glyburide? The pharmacologic basis for better clinical practice. Clin Pharm Therap 2009;85:607-6114.
78. Paglia MJ, Coustan DR. The use of oral antidiabetic medications in gestational diabetes mellitus. Curr Dis Reps 2009;9:287-290.
79. Kitzmiller JL, Block JM, Brown FM et al. Managing preexisting diabetes for pregnancy. Summary of evidence and consensus recommendations for care. Diabetes Care 2008;31:1060-79.
80. Barbour LA, Diabetes in Pregnancy. In Endocrine Secrets, McDermott M ed. Mosby Elsevier 2009, Philadelphia:47-64.
81. Cooper WO, Hernandez-Diaz S, Arbogast PG et al. Major congenital malformations after first-trimester exposure to ACE Inhibitors. NEJM 2006;354:2443-51.
82. Pryde PG, Sedman AB, Nugent CE, Barr M. Angiotensin-converting enzyme fetopathy. J Am Soc Nephol 1993;3:1575-82.
83. National High Blood Pressure Education Program. National high blood pressure education program working group report on high blood pressure in pregnancy. Am J Obstet Gynecol 1990;163:1691-712.
84. Kitzmiller JL, Block JM, Brown FM et al. Managing preexisting diabetes for pregnancy. Summary of evidence and consensus recommendations for care. Diabetes Care 2008;31:1060-79.
85. Rossing K, Jacobsen P, Hommel E, Mathiesen E, Svenningsen A, Rossing P, Parving HH. Pregnancy and progression of diabetic nephropathy. Diabetologia 2002;45(1):36-41.
86. Kimmerle R, ZaB RP, Cupisti S, Somville T, Bender R, Pawlowski B, Berger M. Pregnancies in women with diabetic nephropathy: long-term outcome for mother and child. Diabetologia 1995;38:227-35.
87. Sabai BM, Caritis S,Hauth J, Lindheimer M, Van Dorsten JP. Risks of preeclampsia and adverse neonatal outcomes among women with pregestational diabetes melllitus. Am J Obstet Gynecol 2000;182:364-9.
88. Landon MB. Diabetic nephropathy and pregnancy. Clinical Obstet Gynecol 2007;50:998-1006.
89. Sabai BM, Caritis S,Hauth J, Lindheimer M, Van Dorsten JP. Risks of preeclampsia and adverse neonatal outcomes among women with pregestational diabetes melllitus. Am J Obstet Gynecol 2000;182:364-9.
90. Landon MB. Diabetic nephropathy and pregnancy. Clinical Obstet Gynecol 2007;50:998-1006.
91. Sabai BM, Caritis S,Hauth J, Lindheimer M, Van Dorsten JP. Risks of preeclampsia and adverse neonatal outcomes among women with pregestational diabetes melllitus. Am J Obstet Gynecol 2000;182:364-9.
92. Barbour LA, Laiffer SA. Preconception counseling. In Lee RV, Rosene-Montella K, Barbour LA, Garner PR, Keely E (ed): Medical Care of the Pregnant Patient, Philadelphia, American College of Physicians 2000:1-18.
93. Temple RC, Aldridge VA, Sampson MJ, Greenwood RH, Heyburn PJ, Glenn A. Impact of pregnancy on the progression of diabetic retinopathy in Type 1 diabetes. Diabetic Med 2001;18(7):573-7.
94. Sheth BP. Does pregnancy accelerate the rate of progression of diabetic retinopathy: an update. Curr Diab Rep 2008;8:270-73.
95. American Diabetes Association. Preconception care of women with diabetes, Diabetes Care 23:S65-68, 2000.
96. Abalovich M, Amino A, Barbour LA et al. Management of thyroid dysfunction during pregnancy and postpartum: An Endocrine Society and clinical practice guideline. J Clin Endorinol Metab 2007;92:S1-S47.
97. Kitzmiller JL, Block JM, Brown FM et al. Managing preexisting diabetes for pregnancy. Summary of evidence and consensus recommendations for care. Diabetes Care 2008;31:1060-79.
98. Abalovich M, Amino A, Barbour LA et al. Management of thyroid dysfunction during pregnancy and postpartum: An Endocrine Society and clinical practice guideline. J Clin Endorinol Metab 2007;92:S1-S47.
99. Rosenn BM, Menachem M. Medical complications of diabetes mellitus in pregnancy. Clinical Obstet Gynecol 2000;43(1):17-31.
100. Kitzmiller JL, Block JM, Brown FM et al. Managing preexisting diabetes for pregnancy. Summary of evidence and consensus recommendations for care. Diabetes Care 2008;31:1060-79.
101. Kitzmiller JL, Block JM, Brown FM et al. Managing preexisting diabetes for pregnancy. Summary of evidence and consensus recommendations for care. Diabetes Care 2008;31:1060-79.
102. Garner P. Type I diabetes and pregnancy. Lancet 346:157-161, 1995.
103. Verge CF, Gianna R, Kawasaki E, Yu L, Pietropaolo M, Jackson RA Chase HP, Eisenbarth GS. Prediction of type 1 diabetes in first degree relatives using a combination of insulin GAD, and ICA512bdc/IA-2 autoantibodies. Diabetes 1996;45:926-33.
104. Barbour LA. New concepts in insulin resistance of pregnancy and gestaional diabetes: long-term mplications for mother and offspring. J Obstet Gynaecol 2003;23:545-9.
105. Dabelea D. The predisoposition to obesity and diabetes in offspring of diabetic mothers. Diabetes Care 2007;30:S169-S174.
106. Catalano PM, Farrel K, Thomas A et al. Perinatal risk factors for childhood obesity and metabolic dysregulation. Am J Clin Nutr 2009;
107. Barbour LA, Laiffer SA. Preconception counseling. In Lee RV, Rosene-Montella K, Barbour LA, Garner PR, Keely E (ed): Medical Care of the Pregnant Patient, Philadelphia, American College of Physicians 2000:1-18
108. Yogev Y, Catalano PM. Pregnancy and obesity. Obstet Gynecol Clin N Am 2009;36:285-300.
109. Uplinger N. The controversy coninutes: nutritional management of the pregnancy complicated by diabetes. Curr Diab Rep 2009;9:291-95.
110. Reader DM. Medical nutrition therapy and lifestyle interventions. Diabetes Care 2007;30:S118-S193.
111. Institute of Medicine. Weight gain during pregnancy: Reexamining the guidelines. Washington, DC: The National Academic Press, 2009.
112. Uplinger N. The controversy coninutes: nutritional management of the pregnancy complicated by diabetes. Curr Diab Rep 2009;9:291-95.
113. ACOG Committee Opinion. Obesity in Pregnancy. #315, Sept 2005.
114. Kitzmiller JL, Block JM, Brown FM et al. Managing preexisting diabetes for pregnancy. Summary of evidence and consensus recommendations for care. Diabetes Care 2008;31:1060-79.
115. Knopp RH, Magee MS, Raisys V et al. Metabolic effects of hypocaloric diets in management of gestational diabetes. Diabetes 1992;40:S165-S171.
116. Makrides M.Is there a dietary requirement for DHA in pregnancy? Prostaglandins Leukot Essent Fatty Acids. 2009 Aug-Sep;81(2-3):171-4.
117. Kitzmiller JL, Block JM, Brown FM et al. Managing preexisting diabetes for pregnancy. Summary of evidence and consensus recommendations for care. Diabetes Care 2008;31:1060-79.
118. DeMaio M, Magann E. Exercise and pregnancy. J Am Acad Orthop Surg 2009;17:504-14.
119. Kitzmiller JL, Block JM, Brown FM et al. Managing preexisting diabetes for pregnancy. Summary of evidence and consensus recommendations for care. Diabetes Care 2008;31:1060-79.
120. Reader DM. Medical nutrition therapy and lifestyle interventions. Diabetes Care 2007;30:S118-S193.
121. Osterdal ML, Strom AK, Knudsen VK et al. Does leisure time physical activity in early pregnancy protect agains pre-eclampsia? Prospective cohort in Danish women. BJOG 2009;116:98-107.
122. Clapp JF. The course of labor after endurance exercise during pregnancy. Am J Obstet Gynecol 1990;163:1799-1805.
123. Clapp JF, Kim H, Burciu B et al. Contining regular exercise during pregnancy: effect of exercise volume on fetoplaental growth. Am J Obstet Gynecol 2002;186:142-47.
124. HAPO Study Cooperative Research Group. Hyperglycemia and Adverse Pregnancy Outcomes. NEJM 2008;358:1991-2002.
125. Hod M, Yogev Y. Goals of metabolic management in gestational diabetes. Diabetes Care 2007;30:S180-S187.
126. American Diabetes Association. Gestational Diabetes Mellitus. Diabetes Care 2001;24(suppl 1) S77-S-79.
127. Kitzmiller JL, Block JM, Brown FM et al. Managing preexisting diabetes for pregnancy. Summary of evidence and consensus recommendations for care. Diabetes Care 2008;31:1060-79.
128. DeViciana M, Major CA, Morgan MA, Asrat T, Toohey JS, et al. Postprandial versus preprandial blood glucose monitoring in women with gestational diabetes mellitus requiring insulin therapy. N Engl J Med 333:1237-1241, 1995.
129. Buchbinder A, Miodovnik M, McElvy S, Rosenn B, Kranias G et al. Is insulin lispro associated with the development or progression of diabetic retinopathy during pregnancy? Am J Obstet Gynecol 2000;183:1162-5.
130. Torlone E, Di Cianni G, Mannino D et al. Insulin analogs and pregnancy: an update. Acta Diabetol 2009;46:163-72.
131. Javanovic L, Ilic S, Pettitt DJ, Hugo K, Gutierrez M, Bowsher RR, Bastyr EJ. Metabolic and immunologic effects of insulin lispro in gestational diabetes. Diabetes Care 1999;22:1422-1427.
132. Mathiesen ERT, Kinsley B, Amiel SA et al. Maternal glycemic control and hypoglycemia in type 1 diabetic pregnancy. Diabetes Care 2007;30:771-76.
133. Barbour LA, Reusch JE-B. Diabetes in Pregnancy. In McDermott M (ed):, Endocrine Secrets, 3rd ed, Philadelphia, Hanley & Belfus, 2001,308-16.
134. Gabbe SG, Carpenter LB, Garrison EA. New strategies for glucose control in patients with type 1 and type 2 diabetes mellitus in pregnancy. Clinical Obstet Gynecol 2007;50:1014-24.
135. Hofmann T, Horstmann G, Stammberger I. Evaluation of the reproductive toxicity and embryotoxicity of insulin glargine (LANTUS) in rats and rabbits. Int J Tox 2002;21(3):181-9.
136. Torlone E, Di Cianni G, Mannino D et al. Insulin analogs and pregnancy: an update. Acta Diabetol 2009;46:163-72.
137. Gabbe SG, Holing E, Temple P, Brown ZA. Benefits, risks, costs, and patient satisfaction associated with insulin pump therapy for the pregnancy complicated by type 1 diabets mellitus. Am J Obstet Gynecol 2000;182:1283-91.
138. Gabbe SG, Carpenter LB, Garrison EA. New strategies for glucose control in patients with type 1 and type 2 diabetes mellitus in pregnancy. Clinical Obstet Gynecol 2007;50:1014-24.
139. Gimenez M, Conget I, Nicolau J et al. Outcome of pregnany in women with type 1 diabetes intensvely treated with continuous subcutaneous insulininfusion or conventional therapy-a case-control study. Acta Diabetol 2007;44:34-37.
140. Mukhopadhyay A, Farrell T, Fraser RB et al. Continuous subcutaneous insulin infusion vs intensive conventional insulin thereapy in pregant diabetic women: a systematic review and metaanalysis of randomized, controlled trials. Am J Obstet Gynecol 2007:447-56.
141. Nachum Z, Ben-Schlomo I, Weiner E, Salev E. Twice dialy versus four times daily insulin dose regimens for diabetes in pregnancy: randomized controlled trial. BMJ 1999;319:1223-7.
142. Rosenn B, Miodovnik M, Holcberg G et al. Hypoglycemia: the pirce of intensive therapy in insulin dependent diabetes mellitus pregnancies. Obste Gynecol 1995;85:417-22.
143. Rosenn B, Miodovnik M, Khoury J et al. Counterregulatory responses to hypoglycemia in pregnant women witn insulin-dependent diabetes mellitus. Obstet Gynecol 1996;87:568-74.
144. Bjorklund A, Adamson U, Andreasson K et al. Hormonal counterregulation and subjective symptoms during induced hypoglycemia in insulin-dependent diabetes mellitus patients during and after pregnancy. Acta Obstet Gynecol Scand 1998;77:625-35.
145. Keely E. Obesity. In Medical Care of the Pregnant Patient, Rosene-Montella K, Keely E, Barbour LA, Lee RV second edition. American College of Physicians 2008, Philadelphia: 209-215.
146. Kenshole A, Ray J, Keely E. Type 1 and Type 2 Diabetes. In Lee RV, Rosene-Montella K, Barbour LA, Garner PR, Keely E (ed): Medical Care of the Pregnant Patient, Philadelphia, American College of Physicians 2000, pp 253-272.
147. Murphy HR, Rayman G, Lewis K et al. Effectiveness of continuous glucose monitoring in pregnant women with diabetes: randomized clinical trial. BMJ 2008:337:1680
148. Ter Braak EW, Evers IM, Erkelens D, Visser GH. Maternal hypoglycemia during pregnancy in type 1 diabetes: maternal and fetal consequences. Diabetes/Metab Res Rev 2002:18(2):96-105.
149. Ter Braak EW, Evers IM, Erkelens D, Visser GH. Maternal hypoglycemia during pregnancy in type 1 diabetes: maternal and fetal consequences. Diabetes/Metab Res Rev 2002:18(2):96-105.
150. Ryan EA. Pregnancy in diabetes. Med Clin No Amer 1998;82(4):823-45.
151. Landon MB. Obststric management of pregnancies complicated by diabetes mellitus. Clinical Obstet Gynecol 2000;43(1):65-74.
152. Leveno KJ. Overt diabetes complicating pregnancy. Williams Obstet Supp;Dec 1996/Jan 1997;22:1-14.
153. Schaefer-Graf UM, Graf K, Kulbacka I et al. Maternal lipids as strong determinants of fetal environment and growth in pregnancies with gestional diabetes mellitus. Diabetes Care 2008;31:1858-63.
154. Buchanan TA, Kjos SI, Montoro MN et al. Use of fetal ultrasound to select metabolic therapy for pregnancies complicated by mild gestational diabetes. Diabetes Care 1994;17(4);275-83.
155. Buchanan TA, Kjos SI, Montoro MN et al. Use of fetal ultrasound to select metabolic therapy for pregnancies complicated by mild gestational diabetes. Diabetes Care 1994;17(4);275-83.
156. Bonomo M, Cetin I, Pisoni MP et al. Flesible treatment of gestational diabetes modulated on ultrasound evaluation of intruterine growth: a controlled randomized clinical trial. Diab Metab 2004;30:237-44.
157. Kjos SL, Schaefer-Graf UM. Modified therapy for gestational diabetes using high-risk and low-risk fetal abdominal circumference growth to select stric versus relaxed maternal glycemic targets. Diabetes Care 2007;30:S200-205.
158. Landon MB. Obststric management of pregnancies complicated by diabetes mellitus. Clinical Obstet Gynecol 2000;43(1):65-74.
159. ACOG Practice Bulletin, Gabbe SG. Pregestatational diabetes mellitus. No. 60, March 2005.
160. Galan, HL, Hobbins, JC. Antepartum fetal surveillance. In Lee RV, Rosene-Montella K, Barbour L, Garner PR, Keely E (ed). Medical Care of the Pregnant Patient, Philadelphia, American College of Physicians 2000:87-103.
161. ACOG Practice Bulletin, Gabbe SG. Pregestatational diabetes mellitus. No. 60, March 2005.
162. Landon MB. Obststric management of pregnancies complicated by diabetes mellitus. Clinical Obstet Gynecol 2000;43(1):65-74.
163. Keely E, Montoro MM. Type 1 and Type 2 Diabetes. In Medical Care of the Pregnant Patient, Rosene-Montella K, Keely E, Barbour LA, Lee RV second edition. American College of Physicians 2008, Philadelphia:233-252.
164. ACOG Practice Bulletin, Gabbe SG. Pregestatational diabetes mellitus. No. 60, March 2005.
165. Gabbe SG, Carpenter LB, Garrison EA. New strategies for glucose control in patients with type 1 and type 2 diabetes mellitus in pregnancy. Clinical Obstet Gynecol 2007;50:1014-24.
166. Keely E, Montoro MM. Type 1 and Type 2 Diabetes. In Medical Care of the Pregnant Patient, Rosene-Montella K, Keely E, Barbour LA, Lee RV second edition. American College of Physicians 2008, Philadelphia:233-252.
167. Keely E, Montoro MM. Type 1 and Type 2 Diabetes. In Medical Care of the Pregnant Patient, Rosene-Montella K, Keely E, Barbour LA, Lee RV second edition. American College of Physicians 2008, Philadelphia:233-252.
168. Gold AE, Reilly C, Walker JD. Transient improvement in glycemic control. Diabetes Care 1998;21(3):374-8
169. Ryan EA. Pregnancy in diabetes. Med Clin No Amer 1998;82(4):823-45
170. Kenshole A, Ray J, Keely E. Type 1 and Type 2 Diabetes. In Lee RV, Rosene-Montella K, Barbour LA, Garner PR, Keely E (ed): Medical Care of the Pregnant Patient, Philadelphia, American College of Physicians 2000, pp 253-272.
171. Briggs GC, Freeman RK, Yaffee SJ. Drugs in pregnancy and lactation, 6th edition. Baltimore: Williams and Wilkins 2001
172. Gerstein HC. Incidence of postpartum thyroid dysfunctionin patients with type 1 diabetes mellitus. Ann Int Med 1993;118:419-23
173. Abalovich M, Amino A, Barbour LA et al. Management of thyroid dysfunction during pregnancy and postpartum: An Endocrine Society and clinical practice guideline. J Clin Endorinol Metab 2007;92:S1-S47.
174. Barbour LA. Thyroid disease in pregnancy. In McDermott M (ed):, Endocrine Secrets, 3rd ed, Philadelphia, Hanley & Belfus, 2001:308-16
175. Kjos SL. After pregnancy complicated by diabetes: postpartum care and education. Obstet Gynecol Clins of No Amer 2007;34:335-349.
176. Ryan EA. Pregnancy in diabetes. Med Clin No Amer 1998;82(4):823-45.
177. Plagemann A, Harder T, Franke K et al. Long term inpact of neonatal breastfeeding on body weight and glucose tolerance in children of diabetic mothers. Diabetes Care 2002;25:16-22.
178. Feig DS, Briggs GG, Kraemer JM et al. Transfer of glyburide and glipizide into breat milk. Diabetes Care 2005;28:1851-55.
179. Glatstein MM, Djokanovic N, Garcia-Bournissen F et al. Use of hypoglycemic drugs during lactaion. Canad Fam Phys 2009;55:371-373.
180. Kjos SL. Postpartum care of the woman with diabetes. Clinical Obstet Gynecol 43:75-90, 2000.
181. Damm,P, Mathiesen ER, Petersen KR et al. Contraception after gestational diabetes. Diabetes Care 2007;30:S236-41.
182. Stamm CA, Barbour, LA, McGregor JA. Effective birth control for women with medical disorders. In Lee, RV, Rosene-Montella K, Barbour LA, Garner PR, Keely E (ed). Medical care of the pregnant patient. Philadelphia, American College of Physicians 2000:19-33
183. Skouby SO, Molsted-Pedersoen L, Huhl C, Bennet P. Oral contraceptives in diabetic women: metabolic effects of four compounds with different estrogen/progesterone profiles. Fertil Steril 1986;46:858-64.
184. Damm,P, Mathiesen ER, Petersen KR et al. Contraception after gestational diabetes. Diabetes Care 2007;30:S236-41.
185. Kjos SL. After pregnancy complicated by diabetes: postpartum care and education. Obstet Gynecol Clins of No Amer 2007;34:335-349.
186. ) Kjos SL. Postpartum care of the woman with diabetes. Clinical Obstet Gynecol 43:75-90, 2000
187. Kjos SL. After pregnancy complicated by diabetes: postpartum care and education. Obstet Gynecol Clins of No Amer 2007;34:335-349.
188. Barbour LA, Diabetes in Pregnancy. In Endocrine Secrets, McDermott M ed. Mosby Elsevier 2009, Philadelphia:47-64.
189. Chauhan SP, Perry Jr KG. Management of diabetic ketoacidosis in the obstetric patient. Obstet Gynecol Clin No America 1995;22(1):143-55.
190. Carroll MA, Yeomans ER. Diabetic ketoacidosis in pregnancy. Crit Care Med 2005;33:S347-S353.
191. Hagay ZJ. Dibetic Ketoacidosis in pregnancy: Etiology, pathophysiology, and management. Clinical Obstet Gynecol 1994;37(1):39-49.
192. Ramin KD. Diabetic ketoacidosis in pregnancy. Obstet Gynecol Clin No Amer 1999;26(3):481-87.
193. Cullen MT, Reece EA, Homko CJ et al. The changing presentations of diabetic ketoacidosis during pregnancy. Am J Pernat 1996;13(7):449-51.
194. Parker JA, Conway DL. Diabetic ketoacidosis in pregnancy. Obstet Gynecol Clin N Amer 2007;34:533-43.
195. Mahoney CA. Extreme gestational starvation ketoacidosis: Case report and review of pathophysiology. Am J Kidney Dis 1992;XX(3):276-80.
196. Montoro MN, Myers VP, Mestman JH, et al. Outcome of pregnancy in diabetic ketoacidosis. Am J Perinatol 1993;10(1)17-20.
197. Rodgers BD, Rodgers DE. Clinical variables associated with diabetic ketoacidosis during pregnancy. J Reprod Med 1991;36(11):797-99.
198. Rodgers BD, Rodgers DE. Clinical variables associated with diabetic ketoacidosis during pregnancy. J Reprod Med 1991;36(11):797-99.
199. Mahoney CA. Extreme gestational starvation ketoacidosis: Case report and review of pathophysiology. Am J Kidney Dis 1992;XX(3):276-80.
200. Aldoretta PW, Hay WW. Metabolic substrates for fetal energy metabolism and growth. Clin Perinatol 1995;22(1):15-35.
201. Whiteman VE, Homdo CJ, Reece EA. Management of hypoglycemia and diabetic ketoacidosis in pregnancy. Obst Gynecol Clin No America 1996;23(1):87-107
202. Biesenbach G, Zazgornik J. Incidence of transient nephrotic syndrome during pregnany in diabetic women with and without pre-existing microalbuminuria. BMJ 1989;299366-7.
203. Smith MC, Moran P, Ward MK et al. Assessment of glomerular filtration rate during pregnancy using the MDRD formulat. BJOG 2008;115:109-12.
204. Kitzmiller JL, Block JM, Brown FM et al. Managing preexisting diabetes for pregnancy. Summary of evidence and consensus recommendations for care. Diabetes Care 2008;31:1060-79.
205. Rosenn BM, Menachem M. Medical complications of diabetes mellitus in pregnancy. Clinical Obstet Gynecol 2000;43(1):17-31.
206. Rossing K, Jacobsen P, Hommel E, Mathiesen E, Svenningsen A, Rossing P, Parving HH. Pregnancy and progression of diabetic nephropathy. Diabetologia 2002;45(1):36-41.
207. Reece EA, Winn HN, Haylsett JP, Coulehan J, Wan M, Hobbins JC. Does pregnancy alter the rate of progression of diabetic nephropathy? Am J Pernatol 1990;7(2):193-7.
208. Kitzmiller JL, Gavin LA, Gin GD et al. Preconception care of diabetes--glycemic control prevents congenital anomalies. JAMA 1991;265:731-6.
209. Landon MB. Diabetic nephropathy and pregnancy. Clinical Obstet Gynecol 2007;50:998-1006.
210. Kimmerle R, ZaB RP, Cupisti S, Somville T, Bender R, Pawlowski B, Berger M. Pregnancies in women with diabetic nephropathy: long-term outcome for mother and child. Diabetologia 1995;38:227-35.
211. Kimmerle R, ZaB RP, Cupisti S, Somville T, Bender R, Pawlowski B, Berger M. Pregnancies in women with diabetic nephropathy: long-term outcome for mother and child. Diabetologia 1995;38:227-35.
212. Beisenbach G, Grafinger P, Zazgornik J, Helmut, Stoger. Perinatal complications and three-year follow up of infants of diabetic mothers with diabetic nephropathy stage IV. Renal Failure 2000;22(5):573-80.
213. Ekbom P, Damm P, Feldt-Rasmussen B, Feldt-Rasmussen U, Molvig J, Mathiesen ER. Pregnancy outcome in type 1 diabetic women with microalbuminuria. Diabetes Care 2001;24(10):1739-44.
214. Rosenn BM, Menachem M. Medical complications of diabetes mellitus in pregnancy. Clinical Obstet Gynecol 2000;43(1):17-31.
215. Leguzamon G, Reece EA. Effect of medical therapy on progressive nephropathy: influence of pregnancy, diabetes, and hypertension. J Mat-Fet Med 2000;9(1):70-78.
216. Carr DB, Koontz GL, Gardella C et al. Diabetic nephropathy in pregnancy: suboptimal hypertensive control associated with preterm delivery. AJH 2006;19:513-19.
217. Nielsen GL, Moller M, Sorensen HT. HbA1c in early diabetic pregnancy and pregnantcy outcomes. Diabetes Care 2006;29:2612-16.
218. Kitzmiller JL, Block JM, Brown FM et al. Managing preexisting diabetes for pregnancy. Summary of evidence and consensus recommendations for care. Diabetes Care 2008;31:1060-79.
219. Carr DB, Koontz GL, Gardella C et al. Diabetic nephropathy in pregnancy: suboptimal hypertensive control associated with preterm delivery. AJH 2006;19:513-19.
220. Cooper WO, Hernandez-Diaz S, Arbogast PG et al. Major congenital malformations after first-trimester exposure to ACE Inhibitors. NEJM 2006;354:2443-51.
221. Bar J, Ben-Rafael Z, Padoa A, Orvieto R, Boner G, Hod M. Prediction of pregnancy outcome in subgroups of women with renal disease. Clinical Nephrol 2000;53(6);437-44.
222. Sheth BP. Does pregnancy accelerate the rate of progression of diabetic retinopathy: an update. Curr Diab Rep 2008;8:270-73.
223. Rosenn BM, Menachem M. Medical complications of diabetes mellitus in pregnancy. Clinical Obstet Gynecol 2000;43(1):17-31.
224. Diabetes Control and Compliations Trial Research Group. Effect of pregnancy on microvascular complications in the diabetes control and complications trial. Diabets Care 2000;23:1084-91.
225. Temple RC, Aldridge VA, Sampson MJ, Greenwood RH, Heyburn PJ, Glenn A. Impact of pregnancy on the progression of diabetic retinopathy in Type 1 diabetes. Diabetic Med 2001;18(7):573-7.
226. Axel-Siegel R, Hod M, Fink-Cohen S et al. Diabetic retinopathy during pregnancy. Opthalmol 1996; 103:1815-19.
227. Chew EY, Mills JL, Metzger BE, Remaley NA, Jovanovic-Peterson L et al. Metabolic control and progression of retinopathy; the diabetes in early pregnancy study. Diabetes Care 1995;18(5);631-7.
228. Kitzmiller JL, Block JM, Brown FM et al. Managing preexisting diabetes for pregnancy. Summary of evidence and consensus recommendations for care. Diabetes Care 2008;31:1060-79.
229. Lauszus F, Klebe JG, Bek T. Diabetic retinopathy in pregnancy during tight metabolic control. Acta Obstet Gynecol Scand 2000;79(5):367-70.
230. Kitzmiller JL, Block JM, Brown FM et al. Managing preexisting diabetes for pregnancy. Summary of evidence and consensus recommendations for care. Diabetes Care 2008;31:1060-79.
231. Rosenn BM, Menachem M. Medical complications of diabetes mellitus in pregnancy. Clinical Obstet Gynecol 2000;43(1):17-31.
232. Rosenn BM, Menachem M. Medical complications of diabetes mellitus in pregnancy. Clinical Obstet Gynecol 2000;43(1):17-31.
233. Kitzmiller JL, Block JM, Brown FM et al. Managing preexisting diabetes for pregnancy. Summary of evidence and consensus recommendations for care. Diabetes Care 2008;31:1060-79.
234. Barbour LA, Laiffer SA. Preconception counseling. In Lee RV, Rosene-Montella K, Barbour LA, Garner PR, Keely E (ed): Medical Care of the Pregnant Patient, Philadelphia, American College of Physicians 2000:1-18.
235. Kitzmiller JL, Block JM, Brown FM et al. Managing preexisting diabetes for pregnancy. Summary of evidence and consensus recommendations for care. Diabetes Care 2008;31:1060-79.
236. Briggs GC, Freeman RK, Yaffee SJ. Drugs in pregnancy and lactation, 6th edition. Baltimore: Williams and Wilkins 2001.
237. Clausen TD, Mathiesen E, Ekbom P et al. Poor pregnancy outcome in women with type 2 diabetes. Diabetes Care 2005;28:323-28.
238. Roland JM, Murphy HR, Ballt V et al. The pregnancies of women with type 2 diagetes: poor outcomes but opportunities for improvement. Diabet Med 2005;22:1274-77.
239. Cundy T, Gamble G, Neale L et al. Differing causes of pregnancy loss in type 1 and type 2 diabetes. Diabetes Care 2007;30:2603-07.
240. Keely E. Obesity. In Medical Care of the Pregnant Patient, Rosene-Montella K, Keely E, Barbour LA, Lee RV second edition. American College of Physicians 2008, Philadelphia: 209-215.
241. Cundy T, Gamble G, Neale L et al. Differing causes of pregnancy loss in type 1 and type 2 diabetes. Diabetes Care 2007;30:2603-07.
242. ACOG Committee Opinion. Obesity in Pregnancy. #315, Sept 2005.
243. Gunderson RP. Childbearing and obesity in women: weight before, during, and after pregnancy. Obstet Gynecol Clin N Am 2009;36:317032.
244. Yogev Y, Catalano PM. Pregnancy and obesity. Obstet Gynecol Clin N Am 2009;36:285-300.
245. ACOG Committee Opinion. Obesity in Pregnancy. #315, Sept 2005.
246. Gunderson RP. Childbearing and obesity in women: weight before, during, and after pregnancy. Obstet Gynecol Clin N Am 2009;36:317032.
247. Weiss JL, Malone FD, Emig D et al. FASTER Research Consortium. Obesity, obstetric complications, and cearean delivery rate: a population-based screening study. Am J Obstet Gynecol 2004;190:1091-7.
248. Yogev Y, Catalano PM. Pregnancy and obesity. Obstet Gynecol Clin N Am 2009;36:285-300.
249. Catalano PM. Management of obesity in pregnancy. Obstet Gynecol 2007:109:419-33.
250. Yogev Y, Catalano PM. Pregnancy and obesity. Obstet Gynecol Clin N Am 2009;36:285-300.
251. Gunderson RP. Childbearing and obesity in women: weight before, during, and after pregnancy. Obstet Gynecol Clin N Am 2009;36:317032.
252. Keely E. Obesity. In Medical Care of the Pregnant Patient, Rosene-Montella K, Keely E, Barbour LA, Lee RV second edition. American College of Physicians 2008, Philadelphia: 209-215.
253. Catalano PM. Management of obesity in pregnancy. Obstet Gynecol 2007:109:419-33.
254. Whitaker RC. Predicting preschooler obesity at birth: the role of maternal obesity in early pregnancy. Pediatrics 2004;114:29-36.
255. Yogev Y, Catalano PM. Pregnancy and obesity. Obstet Gynecol Clin N Am 2009;36:285-300.
256. Catalano PM, Thomas A, Huston-Presley et al. Increased fetal adiposity: A very sensitive marker of abnormal in utero development. Am J Obstet Gynecol 2003;189:1697-704.
257. Catalano PM. Management of obesity in pregnancy. Obstet Gynecol 2007:109:419-33.
258. Catalano PM, Thomas A, Huston-Presley L et al. Phenotype of infants of mothers with gestational diabetes. Diabetes Care 2007;30:S156-S60.
259. Catalano PM, Farrel K, Thomas A et al. Perinatal risk factors for childhood obesity and metabolic dysregulation. Am J Clin Nutr 2009;
260. Yogev Y, Catalano PM. Pregnancy and obesity. Obstet Gynecol Clin N Am 2009;36:285-300.
261. Gunderson RP. Childbearing and obesity in women: weight before, during, and after pregnancy. Obstet Gynecol Clin N Am 2009;36:317032.
262. Oken E, Taveras EM, Kleinmann KP et al. Gestational weight gain and child adiposity at age 3 years. Am J Obstet Gynecol 2007;196:322-8.
263. Kiel DW, Dodson EA, Artal R et al. Gestational weight gain and prgnancy outcomes in obese women: how much is enough? Obstet Gynecol 2007:110:752—8.
264. Cedergren MI. Optimal gestational wight gain for body mass index. Obstet Gynecol 2007;110:759-64.
265. Beard JH, Bell RL, Duffy AJ. Reproductive considerations and pregnancy after bariatric surgery: Current evidence and recommendations. Obes Surg 2008:18:1023-27.
266. Guelinckx I, Devlieger R, Vansant G. Reproductive outcome after bariatric surgery: a critical review. Hum Repr Update 2009:15:189-201.
267. Keely E. Obesity. In Medical Care of the Pregnant Patient, Rosene-Montella K, Keely E, Barbour LA, Lee RV second edition. American College of Physicians 2008, Philadelphia: 209-215.
268. Guelinckx I, Devlieger R, Vansant G. Reproductive outcome after bariatric surgery: a critical review. Hum Repr Update 2009:15:189-201.
269. Keely E. Obesity. In Medical Care of the Pregnant Patient, Rosene-Montella K, Keely E, Barbour LA, Lee RV second edition. American College of Physicians 2008, Philadelphia: 209-215.
270. Catalano PM, Farrel K, Thomas A et al. Perinatal risk factors for childhood obesity and metabolic dysregulation. Am J Clin Nutr 2009;
271. Yogev Y, Metzger BE, Hod M. Establishing diagnosis of gestrational diabetes: impact of the hyperglycemia and adverse pregnancy outcome study. Sem Fet Neon Med 2009;14:94-100.
272. Catalano PM, Thomas A, Huston-Presley L et al. Phenotype of infants of mothers with gestational diabetes. Diabetes Care 2007;30:S156-S60.
273. Simeoni U, Barker DJ. Offspring of diabeteic pregnancy: Long-term outcomes. Sem Fet Neonat Med 2009;14:119-24.
274. American Diabetes Association. Gestational Diabetes Mellitus. Diabetes Care 2001;24(suppl 1) S77-S-79.
275. ACOG Practice Bulletin. Clinical Management Guidelines for Obstetrician-Gynecologists. Gestational Diabetes no. 30. Washington :American College of Obstetricians and Gynecologists, 2001.
276. Yogev Y, Metzger BE, Hod M. Establishing diagnosis of gestrational diabetes: impact of the hyperglycemia and adverse pregnancy outcome study. Sem Fet Neon Med 2009;14:94-100.
277. Barbour LA. Gestational Diabetes. In Medical Care of the Pregnant Patient, Rosene-Montella K, Keely E, Barbour LA, Lee RV second edition. American College of Physicians 2008, Philadelphia:216-232
278. Catalano PM, Huston L, Amini SB, Kalhan SC. Longitudinal changes in glucose metabolism during pregnancy in obese women with normal glucose tolerance and gestational diabetes mellitus. Am J Obstet Gynecol 1999;180:903-16.
279. Buchanan TA, Xiang A, Kjos SL et al. What is gestational diabetes? Diabetes Care 2007;30:S105-S111.
280. Barbour LA, Shao J, Qiao L et al. Human placental growth hormone causes severe insulin resistance in transgenic mice. Am J Obstet Gynceol 2002;186:512-7.
281. Handwerger S, Freemark M. The roles of placental growth hormone and placental lactogen in the regulation of human fetal growth and development. J Ped Endocrinol Metab 2000;13:343-56.
282. Zumkeller W. The role of growth hormone and insulin-like growth factors for placental growth and development. Placenta 2000, 21:451-67.
283. Kirwan JP, Hauguel-De Mouzon S, Lepercq J, Challier JC, Huston-Presley L, Friedman JE, Kalhan SC, Catalano PM. TNF-alpha is a predictor of insulin resistance in human pregnancy. Diabetes. 2002 Jul;51(7):2207-13.
284. Ategbo JM, Grissa O, Yessoufou A. Modulation of adipokines and cytokines in gestational diabetes and macrosomia. J Clin Endocrinol Metab 2006;91:4137-4143.
285. Yamada H, Kato EH, Tsuruga R, Ebina Y, Kobashi G, Sagawa T, Makita Z, Koike T, Fujimoto S. Insulin response patterns contribute to different perinatal risks in gestational diabetes. Gynecol Obstet Invest 2001;51:103-9.
286. Buchanan TA, Xiang A, Kjos SL et al. What is gestational diabetes? Diabetes Care 2007;30:S105-S111.
287. Catalano PM, Huston L, Amini SB, Kalhan SC. Longitudinal changes in glucose metabolism during pregnancy in obese women with normal glucose tolerance and gestational diabetes mellitus. Am J Obstet Gynecol 1999;180:903-16.
288. Barbour LA, McCurdy CE, Hernandez TL et al. Cellular mechanism for insulin resistance in normal pregnany and gestational diabetes. Diabetes Care 2007;30:S112-S119.
289. Kuhl C. Etiology and pathogenesis of gestational diabetes. Diabetes Care 21:B19-26, 1998
290. Barbour LA. Gestational Diabetes. In Medical Care of the Pregnant Patient, Rosene-Montella K, Keely E, Barbour LA, Lee RV second edition. American College of Physicians 2008, Philadelphia:216-232
291. Friedman JE, Ishizuka T, Shao J, Huston L, Highman T, Catalano P. Impaired glucose transport and insulin receptor tyrosine phosphorylation in skeletal muscle from obese women with gestational diabetes. Diabetes 1999;48:1807-14.
292. Shao J, Catalano PM, Yamashita H, Ruyter I, Smith S, Youngren J, Friedman JE. Decreased insulin receptor tyrosine kinase activity and plasma cell membrane glycoprotein-1 overexpression in skeletal muscle from obese women with gestational diabetes (GDM). Diabetes 2000;610:603-10.
293. Barbour LA, McCurdy CE, Hernandez TL et al. Cellular mechanism for insulin resistance in normal pregnany and gestational diabetes. Diabetes Care 2007;30:S112-S119.
294. Lain KY, Catalano PM. Metabolic Changes in Pregnancy. Clin Obstet Gynecol 2007;50:938-48.
295. Garvey WT, Maianu L, Zhu JH, Hancock JA, Golichowski AM. Multiple defects in the adipocyte glucose transport system cause cellular insulin resistance in gestational diabetes. Diabetes 1993;42:1773-85.
296. Landon MB. Obststric management of pregnancies complicated by diabetes mellitus. Clinical Obstet Gynecol 2000;43(1):65-74.
297. Greenberg LT, Moore TR, Murphy H. Gestational diabetes mellitus: antenatal variables as predictors of postpartum glucose intolerance. Obstet Gynecol 1993;86:97-101.
298. Kaufmann RC, Schleyhahn FT, Huffman DG, Amankwah KS. Gestational diabetes diagnostic criteria: long-term maternal follow-up. Am J Ob Gyn 1995;172:621-5.
299. Major CA, deVeciana M, Weeks J, Morgan MA. Recurrence of gestational diabetes: who is at risk? Am J Obstet Gynecol 1998;179:1038-42.
300. Damm P. Gestational diabetes mellitus and subsequent development of overt diabetes mellitus. Danish Med Bull 1998;45:495-508.
301. Kjos SL, Peters RJ, Xiang A, Henry OA, Montoro M, Buchanan T. Predicting future diabetes in Latino women with gestational diabetes. Diabetes 44:586-591, 1995.
302. Kjos SL. Postpartum care of the woman with diabetes. Clinical Obstet Gynecol 43:75-90, 2000.
303. Uvena-Celebrezze J, Catalano P. The Infant of the woman with gestational diabetes mellitus. Clinical Ob Gyn 2000;43(1):127-139.
304. Buchanan TA, Xiang A, Kjos SL et al. What is gestational diabetes? Diabetes Care 2007;30:S105-S111.
305. Xiang AH, Peters RK, Kjos SL et al. Effect of pioglitazone on pancratic B-cell funstion and diabetes risk in Hispanic women wit prior gestational diabetes. Diabetes 2006;55:517-22.
306. Ratner RE, Christophi CA, Metzger BE et al. Prevention of diabetes in women with a history of gestational diabatetes: effects of metformin and lifestyle interventions. JClin Endocrinol Metab 2008;93:4774-79.
307. Uvena-Celebrezze J, Catalano P. The Infant of the woman with gestational diabetes mellitus. Clinical Ob Gyn 2000;43(1):127-139.
308. Rey E, Attie C. Bonin A. The effect of first-trimester diabetes control on the incidence of macrosomia. Am J Obstet Gynecol 1999;181:202-6.
309. Reece EA, Homko CJ. Why do diabetic women deliver malformed infants? Clicical Obstet Gynecol 2000;43(1):32-45.
310. Kuhl C. Etiology and pathogenesis of gestational diabetes. Diabetes Care 21:B19-26, 1998.
311. Yamashita H, Shao J, Friedman JE. Physiologic and molecular alterations in carbohydrate metabolism during pregnancy and gestational diabetes. Clinical Obstet Gynecol 43:87-98, 2000.
312. Hay Jr WW. Placental supply of energy and protein substrates to the fetus. Acta Pediatr Suppl 1994;405:13-19.
313. Catalano PM, Farrel K, Thomas A et al. Perinatal risk factors for childhood obesity and metabolic dysregulation. Am J Clin Nutr 2009;
314. Catalano PM, Thomas A, Huston-Presley L et al. Phenotype of infants of mothers with gestational diabetes. Diabetes Care 2007;30:S156-S60.
315. Rey E, Attie C. Bonin A. The effect of first-trimester diabetes control on the incidence of macrosomia. Am J Obstet Gynecol 1999;181:202-6.
316. Magee MS, Walden CE, Benedetti TJ, Knopp RH. Influence of diagnostic criteria on the incidence of gestational diabetes and perinatal morbidity. JAMA 1993;269:609-15.
317. Weiss AM, Scholz HS, Haas JH, Tamussino KF. Effect of fetal hyperinsulinemia on oral glucose tolerance test results in patients with gestational diabetes mellitus. Am J Obstet Gynecol 20001:184:470-5.
318. Weiss AM, Scholz HS, Haas JH, Tamussino KF. Effect of fetal hyperinsulinemia on oral glucose tolerance test results in patients with gestational diabetes mellitus. Am J Obstet Gynecol 20001:184:470-5.
319. Schaefer-Graf UM, Graf K, Kulbacka I et al. Maternal lipids as strong determinants of fetal environment and growth in pregnancies with gestional diabetes mellitus. Diabetes Care 2008;31:1858-63.
320. Radaelli T, Lepercq J, Varastehpour A et al. Differential regulation of genes for fetoplacental lipid pathways in pregnancy with gestational and type 1 diabetes mellitus. Amer J Obstet Gynecol 2009:201:
321. Landon MB. Obststric management of pregnancies complicated by diabetes mellitus. Clinical Obstet Gynecol 2000;43(1):65-74.
322. Uvena-Celebrezze J, Catalano P. The Infant of the woman with gestational diabetes mellitus. Clinical Ob Gyn 2000;43(1):127-139.
323. Langer O. Management of gestational diabetes. Clinical Obstet Gynecol 43:106-115, 2000.
324. ) Conway DL. Elective delivery of infants with macrosomia in diabetic women: reduced shoulder dystocia versus increased cesarean deliveries. Am J Obstet Gynecol 1998;178:922-5.
325. Reece EA, Homko CJ. Why do diabetic women deliver malformed infants? Clicical Obstet Gynecol 2000;43(1):32-45.
326. Landon MB. Obststric management of pregnancies complicated by diabetes mellitus. Clinical Obstet Gynecol 2000;43(1):65-74.
327. Lindsay RS, Hanson RL, Bennett PH. Secular trends in birth weight, BMI, and diabetes in the offspring of diabetic mothers. Diabetes Care 2000;23:1249-54.
328. Dabelea D. The predisoposition to obesity and diabetes in offspring of diabetic mothers. Diabetes Care 2007;30:S169-S174.
329. Pettitt DJ, Nelson RG, Saad MF, Bennett PH, Knowler WC. Diabetes and obesity in the offspring of Pima Indian women with diabetes during pregnancy. Diabetes Care 1993;16:310-4.
330. Silverman BL, Metzger BE. Impaired glucose tolerance in adolescent offspring of diabetic mothers. Diabetes Care 18:611-617, 1995.
331. Barbour LA. New concepts in insulin resistance of pregnancy and gestaional diabetes: long-term mplications for mother and offspring. J Obstet Gynaecol 2003;23:545-9.
332. Catalano PM, Thomas A, Huston-Presley L et al. Phenotype of infants of mothers with gestational diabetes. Diabetes Care 2007;30:S156-S60.
333. Catalano PM, Farrel K, Thomas A et al. Perinatal risk factors for childhood obesity and metabolic dysregulation. Am J Clin Nutr 2009;
334. Simeoni U, Barker DJ. Offspring of diabeteic pregnancy: Long-term outcomes. Sem Fet Neonat Med 2009;14:119-24.
335. ACOG Practice Bulletin. Clinical Management Guidelines for Obstetrician-Gynecologists. Gestational Diabetes no. 30. Washington :American College of Obstetricians and Gynecologists, 2001.
336. Brody SC, Harris R, Lohr K. Screening for gestational diabetes: A summary of the evidence for the U.S. Preventive Services Task Force. Obstet Gynecol 2003;101(2):380-92.
337. Crowther CA, Hiller JE, Moses Jr et al for the Austrailian Carbohydrate Intolerance Study in Pregnant Women (ACHOIS) Trial Group. Effect of treatment of gestatinal diabtes mellitus on pregnancy outcomes. N Engl J Med 2005;352:2477-2486.
338. Landon MB, Spong CY, Thom E et al. A multicenter, randomized trial of treatment for mild gestaional diabetes. NEJM 2009;361:1339-48.
339. Crowther CA, Hiller JE, Moses Jr et al for the Austrailian Carbohydrate Intolerance Study in Pregnant Women (ACHOIS) Trial Group. Effect of treatment of gestatinal diabtes mellitus on pregnancy outcomes. N Engl J Med 2005;352:2477-2486.
340. Landon MB, Spong CY, Thom E et al. A multicenter, randomized trial of treatment for mild gestaional diabetes. NEJM 2009;361:1339-48.
341. HAPO Study Cooperative Research Group. Hyperglycemia and Adverse Pregnancy Outcomes. NEJM 2008;358:1991-2002.
342. HAPO Study Cooperative Research Group. Hyperglycemia and Adverse Pregnancy Outcomes Study: Associations with neonatal antrhopometrics. Diabetes 2009;58:453-459.
343. Reece EA, Leguizamon G, Wiznitzer A. Gestational diabetes: the need for common ground. Lancet 2009;373:1789-97.
344. American Diabetes Association. Gestational Diabetes Mellitus. Diabetes Care 2001;24(suppl 1) S77-S-79.
345. Metzger BE, Coustan DR, The Organizing Committee. Summary and recommendations of the Fourth International Workshop-Conference on gestational diabetes mellitus. Diabetes Care 21:B-161-167, 1998.
346. Coustan DR. Making the Diagnosis of Gestational Diabetes Mellitus. Clin Obstet Gynecol 2000;43(1):99-105.
347. Metzger BE, Buchanan TA, Coustan DR et al. Summary and recommendations of the Fifth International Workshp-Confernce on gestational diabetes. Diabetes Care 2007;30S251-260.
348. International Association of Diabetes and Pregnancy Study Groups Consensus Panel. International Association of Diabetes and Pregnancy Study Groups Recommendations on the Diagnosis and Classification of Hyperglycemia in Pregnancy Diabetes Care 2010 33: 676-682
349. Naylor CD, Sermer M, Chen E , Farine D for the Toronto Trihospital Gestational Diabetes Project Investigators. Selective screening for gestational diabetes. N Engl J Med 337:1591-1596, 1997.
350. Danilenki-Dixon DR, Van Winter JT, Nelson RL, Ogburn PL. Universal versus selective gestational diabetes screening: application of 1997 American Diabetes Association recommendations. Am J Obstet Gynecol 1999;181:798-802.
351. DeViciana M, Major CA, Morgan MA, Asrat T, Toohey JS, et al. Postprandial versus preprandial blood glucose monitoring in women with gestational diabetes mellitus requiring insulin therapy. N Engl J Med 333:1237-1241, 1995.
352. Simeoni U, Barker DJ. Offspring of diabeteic pregnancy: Long-term outcomes. Sem Fet Neonat Med 2009;14:119-24.
353. Uplinger N. The controversy coninutes: nutritional management of the pregnancy complicated by diabetes. Curr Diab Rep 2009;9:291-95.
354. McCurdy CE, Bishop JM, Williams SM et al. Maternal high-fat diet triggers lipotoxicity in the fetal livers of nonhuman primates. J Clin Invest 2009;119:323-35.
355. Reader DM. Medical nutrition therapy and lifestyle interventions. Diabetes Care 2007;30:S118-S193.
356. American Diabetes Association. Preconception care of women with diabetes, Diabetes Care 23:S65-68, 2000.
357. Carpenter MW. The role of exercise in pregnant women with diabetes mellitus. Clinical Obstet Gynecol 2000;43(1):56-64.
358. DeMaio M, Magann E. Exercise and pregnancy. J Am Acad Orthop Surg 2009;17:504-14.
359. Carpenter MW. The role of exercise in pregnant women with diabetes mellitus. Clinical Obstet Gynecol 2000;43(1):56-64.
360. DeMaio M, Magann E. Exercise and pregnancy. J Am Acad Orthop Surg 2009;17:504-14.
361. Moore TR. Glyburide for the treatment of gestational diabetes: a critical appraisal. Diabetes Care 2007;30:S209-13.
362. Rowan JA, Hague WM, Wanzhen Gao et al. Metformin versus insulin for the treatment of gestational diabetes. NEJM 2008;358:2003-15.
363. Rowan JA, Hague WM, Wanzhen Gao et al. Metformin versus insulin for the treatment of gestational diabetes. NEJM 2008;358:2003-15.
364. Vanky E, Zahlsen K, Spigset O et al. Placental passage of metformin in women with polycystic ovary syndrome. Fertil Steril 2005;83:1575-15787.
365. Paglia MJ, Coustan DR. The use of oral antidiabetic medications in gestational diabetes mellitus. Curr Dis Reps 2009;9:287-290.
366. Coustan DR. Pharmacological management of gestational diabetes: an overview. Diabetes Care 2007;30:S206-S208.
367. Moore TR. Glyburide for the treatment of gestational diabetes: a critical appraisal. Diabetes Care 2007;30:S209-13.
368. Langer O, Conway DL, Berkus MD, Xenakis EM-J, Gonzales O. A comparison of glyburide and insulin in women with gestational diabetes. N Engl J Med 343:1134-8, 2000.
369. Hebert MF, Ma X, Naraharisetti SB et al. Are we optimizing gestatinl diabetes treatment with glyburide? The pharmacologic basis for better clinical practice. Clin Pharm Therap 2009;85:607-6114.
370. Paglia MJ, Coustan DR. The use of oral antidiabetic medications in gestational diabetes mellitus. Curr Dis Reps 2009;9:287-290.
371. Langer O, Conway DL, Berkus MD, Xenakis EM-J, Gonzales O. A comparison of glyburide and insulin in women with gestational diabetes. N Engl J Med 343:1134-8, 2000.
372. Kahn BF, Davies JK, Lynch AM et al. Predictors of Glyburide failure in the treatment of gestational diabetes. Obstet Gynecol 2006;107;1303-9.
373. Kitzmiller JL, Block JM, Brown FM et al. Managing preexisting diabetes for pregnancy. Summary of evidence and consensus recommendations for care. Diabetes Care 2008;31:1060-79.
374. Paglia MJ, Coustan DR. The use of oral antidiabetic medications in gestational diabetes mellitus. Curr Dis Reps 2009;9:287-290.
375. Hebert MF, Ma X, Naraharisetti SB et al. Are we optimizing gestatinl diabetes treatment with glyburide? The pharmacologic basis for better clinical practice. Clin Pharm Therap 2009;85:607-6114.
376. Kahn BF, Davies JK, Lynch AM et al. Predictors of Glyburide failure in the treatment of gestational diabetes. Obstet Gynecol 2006;107;1303-9.
377. Hebert MF, Ma X, Naraharisetti SB et al. Are we optimizing gestatinl diabetes treatment with glyburide? The pharmacologic basis for better clinical practice. Clin Pharm Therap 2009;85:607-6114.
378. Javanovic L. Role of diet and insulin treatment of diabetes in pregnancy. Clinical Obstet Gynecol 2000;43(1):46-55.
379. Buchanan TA, Kjos SI, Montoro MN et al. Use of fetal ultrasound to select metabolic therapy for pregnancies complicated by mild gestational diabetes. Diabetes Care 1994;17(4);275-83.
380. Bonomo M, Cetin I, Pisoni MP et al. Flesible treatment of gestational diabetes modulated on ultrasound evaluation of intruterine growth: a controlled randomized clinical trial. Diab Metab 2004;30:237-44.
381. Kjos SL, Schaefer-Graf UM. Modified therapy for gestational diabetes using high-risk and low-risk fetal abdominal circumference growth to select stric versus relaxed maternal glycemic targets. Diabetes Care 2007;30:S200-205.
382. Kjos SL, Schaefer-Graf UM. Modified therapy for gestational diabetes using high-risk and low-risk fetal abdominal circumference growth to select stric versus relaxed maternal glycemic targets. Diabetes Care 2007;30:S200-205.
383. Moore LE, Clokey D, Rappaport VJ, Curet LB.Metformin compared with glyburide in gestational diabetes: a randomized controlled trial.Obstet Gynecol. 2010 Jan;115(1):55-9.
384. Langer O, Conway DL, Berkus MD, Xenakis EM-J, Gonzales O. A comparison of glyburide and insulin in women with gestational diabetes. N Engl J Med 343:1134-8, 2000.
385. Landon MB. Obststric management of pregnancies complicated by diabetes mellitus. Clinical Obstet Gynecol 2000;43(1):65-74.
386. Buchanan TA, Kjos SI, Montoro MN et al. Use of fetal ultrasound to select metabolic therapy for pregnancies complicated by mild gestational diabetes. Diabetes Care 1994;17(4);275-83.
387. Landon MB. Obststric management of pregnancies complicated by diabetes mellitus. Clinical Obstet Gynecol 2000;43(1):65-74.
388. Conway DL. Elective delivery of infants with macrosomia in diabetic women: reduced shoulder dystocia versus increased cesarean deliveries. Am J Obstet Gynecol 1998;178:922-5.
389. ACOG Practice Bulletin, Gabbe SG. Pregestatational diabetes mellitus. No. 60, March 2005.
390. Kjos SL, Henry OA, Montoro M, Buchanan TA, Mestman JH. Insulin-requiring diabetes in pregnancy: a randomized trial of active induction of labor and expectant management. Am J Obstet Gynecol 169:611-5, 1993.
391. Diabetes Prevention Program Research Gourp. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393-403.
392. Ratner RE. Prevention of type 2 diabetes in women with previous gestational diabetes. Diabetes Care 2007;30:S242-45.
393. Ratner RE, Christophi CA, Metzger BE et al. Prevention of diabetes in women with a history of gestational diabatetes: effects of metformin and lifestyle interventions. JClin Endocrinol Metab 2008;93:4774-79.
394. Conway DL, Langer O. Effects of new criteria for type 2 diabetes on the rate of postpartum glucose intolerance in women with gestational diabetes. Am J Obstet Gynecol 1999;191:610-4.
395. Greenberg LT, Moore TR, Murphy H. Gestational diabetes mellitus: antenatal variables as predictors of postpartum glucose intolerance. Obstet Gynecol 1993;86:97-101.
396. Kaufmann RC, Schleyhahn FT, Huffman DG, Amankwah KS. Gestational diabetes diagnostic criteria: long-term maternal follow-up. Am J Ob Gyn 1995;172:621-5.
397. Kjos SL. Postpartum care of the woman with diabetes. Clinical Obstet Gynecol 43:75-90, 2000.
398. American Diabetes Association. Gestational Diabetes Mellitus. Diabetes Care 2001;24(suppl 1) S77-S-79.
399. Kitzmiller JL, Dang-Kilduff L, Taslimi MM. Gestational diabetes after delivery: short-term management and long-term risks. Diabetes Care 2007;30:S225-S235.
400. Kjos SL, Peters RJ, Xiang A, Henry OA, Montoro M, Buchanan T. Predicting future diabetes in Latino women with gestational diabetes. Diabetes 44:586-591, 1995.
401. Buchanan TA, Xiang AH, Peters RK, Kjos SL, Marroquin A et al. Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacolgical treatment of insulin resistance in high-risk hispanic women. Diabetes 2002;51(9):2796-803.
402. Xiang AH, Peters RK, Kjos SL et al. Effect of pioglitazone on pancratic B-cell funstion and diabetes risk in Hispanic women wit prior gestational diabetes. Diabetes 2006;55:517-22.
403. Xiang AH, Wang C, Peters RK et al. Coordinate changes in plasma glucose and pancreatic B-cell function in Latino women at high risk for type 2 diabetes. Diabetes 2006;55:1074-79.
404. Buchanan TA, Xiang A, Kjos SL et al. What is gestational diabetes? Diabetes Care 2007;30:S105-S111.
405. Ratner RE, Christophi CA, Metzger BE et al. Prevention of diabetes in women with a history of gestational diabatetes: effects of metformin and lifestyle interventions. JClin Endocrinol Metab 2008;93:4774-79.
406. Ratner RE, Christophi CA, Metzger BE et al. Prevention of diabetes in women with a history of gestational diabatetes: effects of metformin and lifestyle interventions. JClin Endocrinol Metab 2008;93:4774-79.
407. Martorell R, Stein AD, Schroeder DG. Early nutrition and later adiposity. J Nutrition 2001;131(3):874S-80S.
408. Schaefer-Graf UM, Hartmann R, Pawliczak J et al. Association of breast-feeding and early childhood overweight in children from mothrs with gestational diabetes mellitus. Diabetes Care 2006;29:1105-07.
409. Mayer-Davis EJ, Rifas-Shiman SL, Zhou Li et al. Breast-feeding and risk for childhood obesity. Diabetes Care 2006;29:2231-37.
410. Sowers M, Crutchfield M, Jannausch M, Updike S, Corton G. A prospective evaluation of bone mineral change in pregnancy. Obstet Gynecol 1991;77:841-5.
411. Rimm EB, Manson JE, Stampfer MJ et al. Oral contraceptive use and the risk of type 2 (non-insulin dependent) diabetes in a large prospective study of women. Diabetologia 1992;35:967-72.
412. Xiang AH, Wang C, Peters RK et al. Coordinate changes in plasma glucose and pancreatic B-cell function in Latino women at high risk for type 2 diabetes. Diabetes 2006;55:1074-79.
413. Barbour LA. Gestational Diabetes. In Medical Care of the Pregnant Patient, Rosene-Montella K, Keely E, Barbour LA, Lee RV second edition. American College of Physicians 2008, Philadelphia:216-232
414. Damm,P, Mathiesen ER, Petersen KR et al. Contraception after gestational diabetes. Diabetes Care 2007;30:S236-41.
415. Kjos SL. After pregnancy complicated by diabetes: postpartum care and education. Obstet Gynecol Clins of No Amer 2007;34:335-349.